BIO Wants More Binding FDA/Sponsor Meetings As Part Of PDUFA III

The Biotechnology Industry Organization is seeking to use PDUFA reform to write a requirement into FDA's legislative mandate for more binding consultations between BLA sponsors and FDA staff before the actual application review begins